Literature DB >> 21862442

A marked deficiency in circulating and renal IGF-I peptide does not inhibit compensatory renal enlargement in uninephrectomized mice.

Daniel Landau1, Jaclyn Biada, Yu Chen, Sumita Sood, Shoshanah Yakar, Derek Leroith, Yael Segev, Ralph Rabkin.   

Abstract

OBJECTIVE: Increase in kidney IGF-I levels due to its increased trapping from the circulation was hypothesized to be a key mediator of compensatory renal enlargement. We tested this hypothesis using genetically engineered mice with extremely low circulating IGF-I levels.
DESIGN: Both IGF-I deficient (ID) and normal (N) mice underwent a uninephrectomy (UNx) and sacrificed 2 or 9days later.
RESULTS: Initial body weight (BW) and kidney weight (KW) were significantly reduced in ID vs. N mice, while KW/BW ratios were similar. KW increased post-UNx to a comparable extent in ID and N mice (125±4 and 118±6% of pre-UNx KW, p<0.05 vs. C). Kidney IGF-I mRNA levels were similar in the ID and N mice and did not change post-UNx. Kidney IGF-I peptide levels pre-UNx were significantly lower in ID vs. N mice (25±5 vs. 305±39ng/g) and increased in both groups after UNx, remaining low in ID mice (45±4 in ID vs 561±64ng/g in N). IGF type 1 receptor phosphorylation was unchanged.
CONCLUSION: While a severe deficiency of circulating IGF-I impairs body growth, UNx induces a significant and proportional increase in renal mass in ID mice despite markedly decreased kidney IGF-I levels (>90% reduction) and no significant change in receptor phosphorylation. This all suggests that factors other than circulating and locally produced IGF-I are responsible for compensatory renal enlargement.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862442      PMCID: PMC5488277          DOI: 10.1016/j.ghir.2011.07.008

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  25 in total

Review 1.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

2.  Tubuloglomerular feedback responses to acute contralateral nephrectomy.

Authors:  R C Blantz; O W Peterson; S C Thomson
Journal:  Am J Physiol       Date:  1991-05

3.  Intrarenal insulin-like growth factor-1 axis after unilateral nephrectomy in rat.

Authors:  F C Fervenza; T Tsao; F Hsu; R Rabkin
Journal:  J Am Soc Nephrol       Date:  1999-01       Impact factor: 10.121

4.  Chronic hypokalemia enhances expression of the H(+)-K(+)-ATPase alpha 2-subunit gene in renal medulla.

Authors:  K Y Ahn; K Y Park; K K Kim; B C Kone
Journal:  Am J Physiol       Date:  1996-08

5.  Transient increase in renal epidermal growth factor content after unilateral nephrectomy in the mouse.

Authors:  S Kanda; P K Saha; K Nomata; M Taide; N Nishimura; T Igawa; J Yamada; H Kanetake; Y Saito
Journal:  Acta Endocrinol (Copenh)       Date:  1991-02

6.  Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy.

Authors:  Jian-Kang Chen; Jianchun Chen; Eric G Neilson; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2005-03-23       Impact factor: 10.121

7.  Increased distal nephron EGF content and altered distribution of peptide in compensatory renal hypertrophy.

Authors:  S B Miller; S A Rogers; C E Estes; M R Hammerman
Journal:  Am J Physiol       Date:  1992-06

8.  Circulating levels of IGF-1 directly regulate bone growth and density.

Authors:  Shoshana Yakar; Clifford J Rosen; Wesley G Beamer; Cheryl L Ackert-Bicknell; Yiping Wu; Jun-Li Liu; Guck T Ooi; Jennifer Setser; Jan Frystyk; Yves R Boisclair; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

9.  cDNA microarray analysis of adaptive changes after renal ablation in a sclerosis-resistant mouse strain.

Authors:  Brigitta Rumberger; Oliver Vonend; Clemens Kreutz; Jochen Wilpert; Johannes Donauer; Kerstin Amann; Rolf Rohrbach; Jens Timmer; Gerd Walz; Peter Gerke
Journal:  Kidney Blood Press Res       Date:  2007-09-20       Impact factor: 2.687

10.  Serum IGF-I-deficiency does not prevent compensatory skeletal muscle hypertrophy in resistance exercise.

Authors:  Ronald W Matheny; Wayne Matheny; Edward Merritt; Symeon V Zannikos; Roger P Farrar; Martin L Adamo
Journal:  Exp Biol Med (Maywood)       Date:  2008-12-08
View more
  3 in total

Review 1.  Targeting Insulin-Like Growth Factor-I in Management of Neurological Disorders.

Authors:  Rashita Makkar; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Hafiz A Makeen; Mohammed Albratty; Hassan A Alhazmi; Aldulkarim M Meraya
Journal:  Neurotox Res       Date:  2022-04-27       Impact factor: 3.911

Review 2.  Human conditions of insulin-like growth factor-I (IGF-I) deficiency.

Authors:  Juan E Puche; Inma Castilla-Cortázar
Journal:  J Transl Med       Date:  2012-11-14       Impact factor: 5.531

Review 3.  Growth Hormone and IGF1 Actions in Kidney Development and Function.

Authors:  Evgenia Gurevich; Yael Segev; Daniel Landau
Journal:  Cells       Date:  2021-11-30       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.